Search Results
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
Search for other papers by Haiyang Zhang in
Google Scholar
PubMed
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
Search for other papers by Shuo Wu in
Google Scholar
PubMed
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
Search for other papers by Shuyu Hu in
Google Scholar
PubMed
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
Search for other papers by Xianqun Fan in
Google Scholar
PubMed
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
Search for other papers by Xuefei Song in
Google Scholar
PubMed
Search for other papers by Tienan Feng in
Google Scholar
PubMed
Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China
Search for other papers by Huifang Zhou in
Google Scholar
PubMed
intravenous glucocorticoid therapy for thyroid-associated ophthalmopathy . Korean Journal of Radiology 2022 23 664 – 673 . ( https://doi.org/10.3348/kjr.2021.0627 ) 12 Debray TPA Damen JAAG Snell KIE Ensor J Hooft L Reitsma JB Riley RD
Search for other papers by Haitao Zhang in
Google Scholar
PubMed
Search for other papers by Hao Hu in
Google Scholar
PubMed
Search for other papers by Yueyue Wang in
Google Scholar
PubMed
Search for other papers by Xinjie Duan in
Google Scholar
PubMed
Search for other papers by Lu Chen in
Google Scholar
PubMed
Search for other papers by Jiang Zhou in
Google Scholar
PubMed
Search for other papers by Wen Chen in
Google Scholar
PubMed
Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Search for other papers by Weizhong Zhang in
Google Scholar
PubMed
Search for other papers by Xiaoquan Xu in
Google Scholar
PubMed
Search for other papers by Huanhuan Chen in
Google Scholar
PubMed
to intravenous glucocorticoid therapy for TED, while Liu et al. ( 25 ) found that the pretreatment volumetric T2 relaxation time histogram features of the EOMs could help predict the response to GC therapy in TED patients. However, although
Search for other papers by Giulia Lanzolla in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Michele Marinò in
Google Scholar
PubMed
, Menconi F , Leo M , Rocchi R , Latrofa F , et al. Intravenous glucocorticoid therapy for Graves’ ophthalmopathy and acute liver damage: an epidemiological study . Eur J Endocrinol . 2015 Mar ; 172 ( 3 ): 269 – 76 . 10.1530/EJE-14-0712 25661744
Department of Women’s and Children’s Health, Pediatric Endocrinology Unit, Padua University Hospital, Padua, Italy
Search for other papers by Jacopo Manso in
Google Scholar
PubMed
Search for other papers by Simona Censi in
Google Scholar
PubMed
Search for other papers by Cristina Clausi in
Google Scholar
PubMed
Search for other papers by Ilaria Piva in
Google Scholar
PubMed
Search for other papers by Yi Hang Zhu in
Google Scholar
PubMed
Search for other papers by Alberto Mondin in
Google Scholar
PubMed
Search for other papers by Maria Chiara Pedron in
Google Scholar
PubMed
Search for other papers by Susi Barollo in
Google Scholar
PubMed
Search for other papers by Loris Bertazza in
Google Scholar
PubMed
Search for other papers by Giulia Midena in
Google Scholar
PubMed
Search for other papers by Raffaele Parrozzani in
Google Scholar
PubMed
Search for other papers by Caterina Mian in
Google Scholar
PubMed
& Ning G . A prospective, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with graves' ophthalmopathy . Journal of Clinical Endocrinology and Metabolism 2014 99 1999 – 2007 . ( https://doi.org/10.1210/jc
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
trial of intravenous glucocorticoids therapy with different protocols for patients with Graves’ ophthalmopathy . J Clin Endocrinol Metab . 2014 ; 99 ( 6 ): 1999 – 2007 . http://dx.doi.org/10.1210/jc.2013-3919 78 He Y , Mu K , Liu R
Search for other papers by Gerd Krause in
Google Scholar
PubMed
Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Search for other papers by Ralf Schülein in
Google Scholar
PubMed
Zhao LQ , Yu DY , Cheng JW . Intravenous glucocorticoids therapy in the treatment of Graves’ ophthalmopathy: a systematic review and Meta-analysis . Int J Ophthalmol . 2019 Jul ; 12 ( 7 ): 1177 – 86 . 10.18240/ijo.2019.07.20 31341811 2222
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Liyun Shen in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Wei Zhu in
Google Scholar
PubMed
Search for other papers by Qin Jiao in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Yulin Zhou in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Shu Wang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Weiqing Wang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Guang Ning in
Google Scholar
PubMed
-2389 ) 9 Zhu W Ye L Shen L Jiao Q Huang F Han R Zhang X Wang S Wang W Ning G . A prospective, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with Graves’ ophthalmopathy . Journal of
Search for other papers by Jingyue Chen in
Google Scholar
PubMed
Search for other papers by Chenyan Li in
Google Scholar
PubMed
Search for other papers by Weiping Teng in
Google Scholar
PubMed
Search for other papers by Zhongyan Shan in
Google Scholar
PubMed
Search for other papers by Jun Jin in
Google Scholar
PubMed
Search for other papers by Yining Wei in
Google Scholar
PubMed
Search for other papers by Jing Sun in
Google Scholar
PubMed
Search for other papers by Yushu Li in
Google Scholar
PubMed
Search for other papers by Huifang Zhou in
Google Scholar
PubMed
glucocorticoids therapy is regarded as the primary treatment for patients with moderate, severe, and extremely severe cases of TED. 94.55% 95.16% NS 18 For patients who have been inactive or stable for at least 6 months, surgical treatment can be
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Lelio Baldeschi in
Google Scholar
PubMed
Search for other papers by Kostas Boboridis in
Google Scholar
PubMed
Search for other papers by Anja Eckstein in
Google Scholar
PubMed
Search for other papers by George J. Kahaly in
Google Scholar
PubMed
Search for other papers by Claudio Marcocci in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
Search for other papers by Mario Salvi in
Google Scholar
PubMed
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
, randomized trial of intravenous glucocorticoids therapy with different protocols for patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 2014;99:1999-2007. 10.1210/jc.2013-3919 24606088 70 Bartalena L, Krassas GE, Wiersinga W, Marcocci C
Department of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA
Endocrinology Division, Department of Medicine, Walter Reed National Military Medical Center, Bethesda, Maryland, USA
Search for other papers by Henry B Burch in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
Search for other papers by Tomasz Bednarczuk in
Google Scholar
PubMed
Search for other papers by David S Cooper in
Google Scholar
PubMed
Search for other papers by Peter J Dolman in
Google Scholar
PubMed
Search for other papers by Angela M Leung in
Google Scholar
PubMed
Search for other papers by Ilse Mombaerts in
Google Scholar
PubMed
Search for other papers by Mario Salvi in
Google Scholar
PubMed
Search for other papers by Marius N Stan in
Google Scholar
PubMed
of Ophthalmology 2020 104 551 – 556 . ( https://doi.org/10.1136/bjophthalmol-2018-313697 ) 83 Zhao LQ Yu DY Cheng JW . Intravenous glucocorticoids therapy in the treatment of Graves’ ophthalmopathy: a systematic review and meta